Published in Women's Health Weekly, June 12th, 2006
"Node-negative breast cancer patients have a relatively good prognosis, but eventually one-third will die of the disease. Thus, prognostic factors to identify the high-risk group among these patients are needed," researchers in the Netherlands reported.
"We retrospectively determined the MAI for a large series of node-negative breast cancer patients (n=468) with tumours smaller than 5 cm, who only received locoregional treatment," explained W.J. Louwman and colleagues, Eindhoven Cancer Registry. "Patients were followed for up to 29 years; crude and relative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.